PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Symptom | C0239946|liver fibrosis |
| Sentences | 98 |
| PubMedID- 24237300 | In conclusion, at 500 iu/day, oral interferon exerted a borderline suppression effect of virological relapse in chronic hepatitis c patients with mild liver fibrosis. |
| PubMedID- 23222845 | Despite a generally asymptomatic course of hcv infection in children with mild histological changes in the liver, chronic hepatitis c may lead to liver fibrosis, cirrhosis, and even hcc in children and adolescents . |
| PubMedID- 25580959 | Utility of real-time shear wave elastography for assessing liver fibrosis in patients with chronic hepatitis c infection without cirrhosis: comparison of liver fibrosis indices. |
| PubMedID- 22401174 | Progression of chronic hepatitis c leads to liver fibrosis and cirrhosis and is associated with an increased risk to develop hepatocellular carcinoma (hcc) . |
| PubMedID- 24192598 | Background: advanced liver fibrosis frequently develops in patients with chronic hepatitis c coinfected with hiv. |
| PubMedID- 25222787 | The present study was carried out to evaluate the role of 13c-methacetin breath test 13c-mbt) as a non invasive tool for liver fibrosis staging in patients with chronic hepatitis c (chc). |
| PubMedID- 21898504 | Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis c: new algorithms are more precise and entirely noninvasive. |
| PubMedID- 22129438 | These histological classifications permitted the development of several non-invasive tests for the diagnosis of liver fibrosis, mainly due to hepatitis c virus (hcv). |
| PubMedID- 21150136 | The objective of this study was to examine the relationship between urinary lcn2 levels and mmp-9 activity with respect to the stage of liver fibrosis in patients with chronic hepatitis c (chc), and to assess the utility of urine lcn2 as a non-invasive marker of hepatic fibrosis. |
| PubMedID- 25126010 | Objectives: the aim of the study was to investigate the effect of the therapy with peginterferon alfa-2a or alfa-2b plus ribavirin on evolution of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 23092446 | Indeed, low adiponectin levels and reduced adiponectin receptor expression are associated with accelerated development of liver fibrosis in patients with chronic hepatitis c infection . |
| PubMedID- 25970201 | Purpose: the aim of the present prospective european multicenter study was to demonstrate the non-inferiority of point shear wave elastography (pswe) compared to transient elastography (te) for the assessment of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 24842533 | We proposed to evaluate the association between serum indirect bilirubin levels and liver fibrosis in patients with chronic hepatitis c (chc) genotype 1b. |
| PubMedID- 22412904 | This finding represents the first such liver disease association since intronic k8/k18 variants did not associate with liver fibrosis development in patients with chronic hepatitis c infection . |
| PubMedID- 22497817 | End-stage renal disease and african american race are independent predictors of mild liver fibrosis in patients with chronic hepatitis c infection. |
| PubMedID- 23300732 | Notably, a recent cohort study in chronic hepatitis c patients with advanced liver fibrosis showed that acei/arb therapy does not prevent the progression of hepatic fibrosis . |
| PubMedID- 23256120 | Prospective non-invasive follow-up of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 24022803 | Noninvasive assessment of liver fibrosis in patients with chronic hepatitis c (and congenital bleeding disorders): where do we stand. |
| PubMedID- 25534272 | If left untreated, hepatitis c infection can lead to hepatitis, liver fibrosis, cirrhosis and hepatocellular carcinoma. |
| PubMedID- 23082465 | Accurate monitoring of liver fibrosis changes in patients with hepatitis c virus (hcv) infection would be helpful in defining the need to intervene, implement the appropriate response in treatment and to minimize the use of liver biopsy. |
| PubMedID- 22254137 | Validation of hepascore as a predictor of liver fibrosis in patients with chronic hepatitis c infection. |
| PubMedID- 24815325 | We investigated whether levels of cytokines and extracellular matrix proteins in serum and biopsy samples can be used to determine actual stage of liver fibrosis in patients with chronic hepatitis c (chc) and in prognosis. |
| PubMedID- 21296375 | Collectively, these observations provide insight into the mechanism of tgf-beta1 activation, which likely manifest in liver fibrosis associated with hepatitis c infection. |
| PubMedID- 19709360 | T-helper cells and liver fibrosis in hepatitis c virus-monoinfected patients. |
| PubMedID- 20471720 | Retrospective study of fibroscan, apri, fib-4 and forns indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis c monoinfection and hiv coinfection. |
| PubMedID- 20587546 | Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis c infection. |
| PubMedID- 25874509 | Background/aim: to date, liver biopsy has been the gold standard used for the assessment of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 26017074 | Association of caffeine intake and liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 22734850 | Course of liver fibrosis in hiv-hepatitis c virus-coinfected patients depending on the response to hepatitis c therapy. |
| PubMedID- 22761838 | Discovery of novel biomarker candidates for liver fibrosis in hepatitis c patients: a preliminary study. |
| PubMedID- 23626613 | The association of non-o blood group and severity of liver fibrosis in patients with chronic hepatitis c infection. |
| PubMedID- 24308724 | Von willebrand factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis c. |
| PubMedID- 24424890 | Macrophage-related serum biomarkers soluble cd163 (scd163) and soluble mannose receptor (smr) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis c: a pilot study. |
| PubMedID- 21387753 | Age/plt, apri and forns seems to be helpful in prediction of early stage of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 21273523 | liver fibrosis in patients with chronic hepatitis c: noninvasive diagnosis by means of real-time tissue elastography--establishment of the method for measurement. |
| PubMedID- 22761744 | Further, ip-10 assays have also shown promise for liver fibrosis monitoring in patients with chronic hepatitis c viral infection (hcv) . |
| PubMedID- 23298655 | Serum markers of liver fibrosis in patients with chronic hepatitis c infection. |
| PubMedID- 22481681 | Assessment of portal venous index as a non-invasive method for diagnosing liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 20722744 | Impact of hiv on liver fibrosis in men with hepatitis c infection and haemophilia. |
| PubMedID- 25788955 | Assessment of liver fibrosis in patients with chronic hepatitis c is useful to decide the optimal timing of antiviral therapy. |
| PubMedID- 24335341 | Furthermore, te may be useful in predicting the severity of liver fibrosis progression due to recurrence of hepatitis c virus infection or other underlying liver diseases after transplantation. |
| PubMedID- 21507271 | Background: hepatitis c can lead to liver fibrosis and cirrhosis. |
| PubMedID- 24103280 | Conclusions: the elf test is a promising non-invasive method for assessing liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 22893489 | Viscoelasticity-based magnetic resonance elastography for the assessment of liver fibrosis in hepatitis c patients after liver transplantation. |
| PubMedID- 25961575 | These two methods are now recommended for first-line evaluation of liver fibrosis in patients with chronic hepatitis c 6. |
| PubMedID- 25949522 | There have been a number of small prospective human studies that have demonstrated a benefit of acei/arb therapy in the treatment of liver fibrosis associated with hepatitis c . |
| PubMedID- 20665624 | Validation of noninvasive methods for the assessment of liver fibrosis in patients with recurrent hepatitis c after transplantation. |
| PubMedID- 21628926 | Predictive value of the fibrosis scores in patients with chronic hepatitis c associated with liver fibrosis and metabolic syndrome. |
| PubMedID- 20305705 | Non-markov multistate modeling using time-varying covariates, with application to progression of liver fibrosis due to hepatitis c following liver transplant. |
| PubMedID- 22677713 | Early-onset liver fibrosis due to primary hepatitis c virus infection is higher over time in hiv-infected men. |
Page: 1 2